(HealthDay News) — Prostate-specific antigen (PSA) screening likely results in a reduction in prostate cancer-specific mortality, according to a review published online May 15 in the Cochrane Database ...
A retrospective analysis assessed the prognostic value of preoperative ctDNA testing among patients who underwent radical cystectomy for bladder cancer.